Ameriprise’s BioTelemetry, Inc. BEAT Stock Holding History

Ameriprise’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-19,500	Closed	-$1.41M	–	3954
2020 Q4	$1.41M	Buy	+19,500	New	+$1.02M	﹤0.01%	2938

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Ameriprise's BEAT Position: Q1 2021 in Review

Ameriprise sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 248,930 shares — an estimated $17.9M sold.

Ameriprise first reported a position in BEAT in Q3 2013 and held it in 21 quarters. The position peaked at $19M in Q3 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Ameriprise reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Ameriprise sold 248,930 BioTelemetry, Inc. shares in Q1 2021, an estimated $17.9M.
Ameriprise first reported a position in BioTelemetry, Inc. in Q3 2013 and held it in 21 quarters.
Ameriprise's BioTelemetry, Inc. position peaked at $19M in Q3 2018.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Ameriprise's 13F filing for Q1 2021, filed 17 May 2021.